Sign In
Buy GNPX
$0.720
-0.0153 (-2.08%)
At Close: Jun 03, 2026
Genprex Initiates Site Recruitment for Acclaim-1 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer
02:05pm, Monday, 30'th Nov 2020
AUSTIN, Texas--(BUSINESS WIRE)--Genprex commences clinical trial site recruitment for Acclaim-1 clinical trial
AUSTIN, Texas--(BUSINESS WIRE)--Genprex receives conditional FDA acceptance of proprietary name Reqorsa(TM) for lead drug candidate
Genprex to Present at Zooming with LD Micro on October 14, 2020
12:00am, Wednesday, 07'th Oct 2020
Genprex will present at the Zooming with LD Micro virtual event
Genprex Names Seasoned IP Executive, Thomas C. Gallagher, as Senior Vice President of Intellectual Property and Licensing
12:00am, Monday, 21'st Sep 2020
Genprex hires Senior Vice President of IP and Licensing
Genprex to Present at The LD 500 Virtual Conference | | IT Business Net
03:14pm, Wednesday, 26'th Aug 2020
AUSTIN, TX / ACCESSWIRE / August 26, 2020 / Genprex, Inc. ("Genprex" or the "Company") (NASDAQ:GNPX), a clinical-stage gene therapy company developing potentially life-changing tec
Genprex to Present at The LD 500 Virtual Conference
12:00am, Wednesday, 26'th Aug 2020
Genprex's Chairman and CEO will present on September 1, 2020 at the LD 500 Virtual Conference
LD Micro-Announces Preliminary List of Presenters for the LD 500.
07:34pm, Wednesday, 05'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
Homophobic men with traits of toxic masculinity more likely to bully
04:00am, Wednesday, 05'th Aug 2020
Researchers from the US used data from 3,600 men and a new scale of harmful masculinities to explore how toxic masculinity can impact health and society.
Inovio Pharmaceuticals: A Focus On The HPV Pipeline Candidates (NASDAQ:INO)
10:19pm, Sunday, 02'nd Aug 2020
COVID vaccine INO-4800 is just one piece of the Inovio (INO) puzzle. Addressing the Human Papilloma Virus remains a high priority for Inovio.
Merck aims to start 'large pivotal' studies on coronavirus treatment in September
01:33pm, Friday, 31'st Jul 2020
"We will be embarking, probably in September, on very large pivotal studies, and so those are going to be the important ones," a company executive said.
Genprex to Present at Proactive’s One2One Virtual Investor Forum on August 4, 2020
12:17pm, Friday, 31'st Jul 2020
Genprex's CEO will Present at the Proactive Investor Forum on August 4 at 1:40 p.m. ET
Pharma giant Merck raises 2020 outlook, saying the worst of the coronavirus impact is behind it
10:52am, Friday, 31'st Jul 2020
Sales of Merck's blockbuster cancer drug Keytruda helped offset an 8% decline in revenue to $10.87 billion during second quarter from $11.76 billion from a year earlier.
Genprex CEO Participates in a Second-Round Live Interview on the "Big Biz Show"
12:16pm, Thursday, 30'th Jul 2020
Genprex appears live on the Big Biz Show for a second time
China takes control of U.S. consulate in Chengdu
05:44am, Monday, 27'th Jul 2020
The U.S. says it has closed its consulate in Chengdu, China. China ordered the consulate closed in retaliation for a U.S. order to shut down the Chinese...
Oncternal Therapeutics to Host Call on Cirmtuzumab and the Current Treatment Landscape for Mantle Cell Lymphoma
12:00am, Monday, 27'th Jul 2020
Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today
